Medtronic – Global Healthcare Technology Leader
A global leader in healthcare technology, developing solutions for complex medical conditions.
Biopharmaceutical company developing DefenCath to prevent catheter-related bloodstream infections (CRBSIs).
CorMedix Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases.
The company’s primary focus is on addressing catheter-related bloodstream infections (CRBSIs), a serious healthcare-associated infection. Its lead product candidate is DefenCath® (taurolidine, heparin), which is specifically designed to prevent these infections.
CorMedix operates in the biopharmaceutical industry, targeting critical unmet medical needs in infection control.